***Live: Tuesday, October 26, 2021 at 11 EDT | 8am PDT | 5pm CEST | 4pm BST*** Oracle Health Sciences reveals new research conducted to understand the technology adaptations that were made to clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.
The COVID-19 pandemic radically changed the world in an instant and forced adaption across the board. In the Life Sciences industry, those conducting clinical trials had to quickly adjust to support new ways of monitoring and caring for clinical trial participants in a world where physical access was not an option.
As we look toward a post-pandemic world, Oracle , in partnership with Informa Pharma Intelligence conducted a global, industry-wide survey to understand the adaptations that were made to clinical trials during the pandemic, the effect of these adaptations, and the impact of these changes on the future of clinical trials.
The research forecasts the continuation, as well as discontinuation, of certain approaches such as EHR, eSource, ePro, and patient apps – and the impact of these approaches on clinical trial data, quality , and speed. It will also shed light on the industry’s level of confidence in the data generated from these new clinical trial approaches, in comparison to data collected via pre-pandemic methods, and other expectations as we step forward into the post-pandemic world.
Key Learning Objectives:
Join this webinar to also understand if your peers:
Who Should Attend:
PhD - Director of Market Research
Global Vice President Life Science Customer Success
Oracle Health Sciences
Time and Date: Tuesday, October 26, 2021 at 11 EDT | 8am PDT | 5pm CEST | 4pm BST
On demand available after final airing until Oct. 26, 2022
Sponsor: Oracle Health Sciences